DSIP: Molecular Characterization and Analytical Chemistry — A Research Reference

The sequence is tryptophan-alanine-glycine-glycine-aspartate-alanine-serine-glycine-glutamate, written WAGGDASGE in single-letter code. It is a nonapeptide with a molecular weight of approximately 849 daltons. Its isolation and physicochemical characterization were reported in 1977 [1].

The composition is unusual in two respects. Four of the nine residues are glycine — the smallest amino acid, with a hydrogen atom in place of a side chain — which makes the backbone exceptionally flexible; glycine-rich stretches adopt no preferred conformation and behave as genuinely disordered chains. And two residues, the aspartate and the glutamate, carry acidic side chains with no basic residue anywhere to balance them, giving the molecule a distinctly acidic character and a low isoelectric point. That is unusual in this catalogue, where most sequences are net basic.

The tryptophan at position 1 is the only aromatic residue. It gives the peptide measurable absorbance at 280 nanometres, which most short sequences here lack, and it is also the residue most sensitive to light.

This compound is unusual in the catalogue for how much remains uncharacterized at the molecular level. No cell-surface receptor has been established for it. Successive reviews across the 1980s catalogued a broad and often inconsistent body of reported activity while noting that a defined molecular target had not been identified [2, 3], and that position has not materially changed.

For experimental design the implication is direct: there is no binding assay to run, no transducer to measure, and no structural model of a ligand-receptor complex to reason from. Work with this compound is necessarily phenomenological rather than mechanistic, and claims encountered in the older literature should be read with the analytical limitations of that era in mind — the isomerization problem described below was not routinely screened for at the time, and a preparation's actual composition was correspondingly less certain than a modern certificate makes it.

The peptide's flexibility compounds this. A glycine-rich acidic nonapeptide has no stable fold to determine, so the structural characterization available for constrained peptides elsewhere in this catalogue has no counterpart here.

Mass spectrometry confirms the intact molecular mass near 849 daltons and distinguishes the unmodified peptide from the phosphorylated variant reported in the literature, which carries a phosphate on the serine at position 7 and differs by a defined eighty daltons.

Reversed-phase HPLC resolves the main peak from related substances and yields the purity figure — and for this sequence the chromatogram carries information the mass measurement cannot.

The reason is aspartimide formation. Aspartate-containing sequences are prone during synthesis to an internal cyclization in which the side chain closes onto the backbone, forming a five-membered ring. That ring reopens, but it can reopen the wrong way, producing iso-aspartate: the chain rejoined through the side-chain carboxyl instead of the backbone one. The result is a structural isomer with exactly the same molecular mass as the target — invisible to mass spectrometry at any resolution. It is separable chromatographically, usually eluting close to the main peak, which makes this compound the clearest illustration in the catalogue of why the two methods are run together rather than either treated as sufficient.

Glycine following aspartate is the most susceptible arrangement; here the aspartate is followed by alanine, which is less prone but not exempt. It remains the related substance worth looking for on the trace.

Net peptide content accounts for counter-ions and residual water, determining how much peptide a nominal milligram figure represents.

Sealed lyophilized material is stable at ambient temperature for the duration of transit and requires no cold chain in shipping. On receipt, vials are refrigerated and kept out of direct light.

Reconstituted material is held refrigerated and used within the window the receiving facility's protocols specify, and repeated freeze-thaw cycling is avoided.

Two residue-specific notes govern the discipline here. The tryptophan is photosensitive and susceptible to oxidation, so amber vials or foil wrapping during extended handling is standard practice. And the aspartate rearrangement described above is not confined to synthesis — the same chemistry proceeds slowly in solution, faster at alkaline pH, so a peptide clean at manufacture can accumulate the isomer while sitting in a tube. Making solutions up as needed is the mitigation.

The acidic character has a further practical consequence. A peptide is least soluble near its isoelectric point, and for an acidic sequence that point sits low — so mildly acidic media are the wrong choice here, where they suit the basic sequences elsewhere in this catalogue.

DSIP is an investigational compound. It has not been approved by the FDA or any other regulatory authority, and no manufacturing, labeling, or quality standards for an approved product apply to it. Research material is sold strictly for laboratory research use; it must not be administered to humans or animals. Researchers are responsible for compliance with all institutional and jurisdictional requirements governing research chemicals.

Each batch of research-grade DSIP is accompanied by an independent certificate of analysis specific to that lot.

DSIP is a nonapeptide of approximately 849 daltons with the sequence WAGGDASGE — glycine-rich, acidic, and carrying a single aromatic residue at its amino terminus. No cell-surface receptor has been established for it, and reviews spanning the 1980s catalogued reported activity without identifying a defined molecular target. Its distinguishing analytical feature is susceptibility to aspartimide-mediated isomerization, which produces an iso-aspartate species of identical mass that mass spectrometry cannot detect and only chromatography resolves — a rearrangement that continues slowly in solution after the certificate is issued.